CN112971147A - 一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物 - Google Patents
一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物 Download PDFInfo
- Publication number
- CN112971147A CN112971147A CN202110242945.4A CN202110242945A CN112971147A CN 112971147 A CN112971147 A CN 112971147A CN 202110242945 A CN202110242945 A CN 202110242945A CN 112971147 A CN112971147 A CN 112971147A
- Authority
- CN
- China
- Prior art keywords
- magnesium
- total nutrient
- vitamin
- emulsion
- special medical
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000839 emulsion Substances 0.000 title claims abstract description 104
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 83
- 159000000003 magnesium salts Chemical class 0.000 title claims abstract description 59
- 239000000203 mixture Substances 0.000 title claims abstract description 55
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 claims abstract description 39
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 25
- 102000004169 proteins and genes Human genes 0.000 claims abstract description 25
- 238000002156 mixing Methods 0.000 claims abstract description 23
- 229910052943 magnesium sulfate Inorganic materials 0.000 claims abstract description 19
- 235000019341 magnesium sulphate Nutrition 0.000 claims abstract description 19
- 239000000395 magnesium oxide Substances 0.000 claims abstract description 18
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims abstract description 18
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims abstract description 18
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 claims abstract description 13
- 229910000395 dimagnesium phosphate Inorganic materials 0.000 claims abstract description 13
- JLVVSXFLKOJNIY-UHFFFAOYSA-N Magnesium ion Chemical compound [Mg+2] JLVVSXFLKOJNIY-UHFFFAOYSA-N 0.000 claims abstract description 11
- 229910001425 magnesium ion Inorganic materials 0.000 claims abstract description 11
- 238000002360 preparation method Methods 0.000 claims abstract description 7
- 239000000243 solution Substances 0.000 claims description 32
- 235000018102 proteins Nutrition 0.000 claims description 24
- 239000002994 raw material Substances 0.000 claims description 23
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 23
- 229910052500 inorganic mineral Inorganic materials 0.000 claims description 21
- 235000010755 mineral Nutrition 0.000 claims description 21
- 239000011707 mineral Substances 0.000 claims description 21
- 238000003756 stirring Methods 0.000 claims description 18
- 229960003390 magnesium sulfate Drugs 0.000 claims description 17
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 16
- 235000012245 magnesium oxide Nutrition 0.000 claims description 16
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 14
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 14
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 14
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 14
- 230000001954 sterilising effect Effects 0.000 claims description 14
- 239000003995 emulsifying agent Substances 0.000 claims description 13
- 239000003381 stabilizer Substances 0.000 claims description 13
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 12
- 235000019197 fats Nutrition 0.000 claims description 12
- 238000004659 sterilization and disinfection Methods 0.000 claims description 12
- 235000015778 magnesium gluconate Nutrition 0.000 claims description 11
- 239000001755 magnesium gluconate Substances 0.000 claims description 11
- 229960003035 magnesium gluconate Drugs 0.000 claims description 11
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 claims description 11
- 235000016709 nutrition Nutrition 0.000 claims description 11
- 150000001720 carbohydrates Chemical class 0.000 claims description 10
- 235000014633 carbohydrates Nutrition 0.000 claims description 10
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 9
- 235000019742 Vitamins premix Nutrition 0.000 claims description 9
- 239000011575 calcium Substances 0.000 claims description 9
- 229910052791 calcium Inorganic materials 0.000 claims description 9
- 238000000034 method Methods 0.000 claims description 9
- 239000011259 mixed solution Substances 0.000 claims description 9
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 8
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 7
- 239000005018 casein Substances 0.000 claims description 7
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 claims description 7
- 235000021240 caseins Nutrition 0.000 claims description 7
- 229910052802 copper Inorganic materials 0.000 claims description 7
- 239000010949 copper Substances 0.000 claims description 7
- 235000013325 dietary fiber Nutrition 0.000 claims description 7
- 229960000304 folic acid Drugs 0.000 claims description 7
- 235000019152 folic acid Nutrition 0.000 claims description 7
- 239000011724 folic acid Substances 0.000 claims description 7
- 239000008103 glucose Substances 0.000 claims description 7
- 229910052742 iron Inorganic materials 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 239000011734 sodium Substances 0.000 claims description 7
- 229910052708 sodium Inorganic materials 0.000 claims description 7
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 6
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 claims description 6
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 6
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims description 6
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 6
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 6
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 6
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 6
- 229930003268 Vitamin C Natural products 0.000 claims description 6
- 229930003316 Vitamin D Natural products 0.000 claims description 6
- 229930003427 Vitamin E Natural products 0.000 claims description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 6
- 235000020958 biotin Nutrition 0.000 claims description 6
- 239000011616 biotin Substances 0.000 claims description 6
- 229960002685 biotin Drugs 0.000 claims description 6
- 239000000460 chlorine Substances 0.000 claims description 6
- 229910052801 chlorine Inorganic materials 0.000 claims description 6
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 6
- 235000013675 iodine Nutrition 0.000 claims description 6
- 239000011630 iodine Substances 0.000 claims description 6
- 229910052740 iodine Inorganic materials 0.000 claims description 6
- 239000011570 nicotinamide Substances 0.000 claims description 6
- 239000003921 oil Substances 0.000 claims description 6
- 235000019198 oils Nutrition 0.000 claims description 6
- 229940055726 pantothenic acid Drugs 0.000 claims description 6
- 239000011713 pantothenic acid Substances 0.000 claims description 6
- 235000019161 pantothenic acid Nutrition 0.000 claims description 6
- 239000011574 phosphorus Substances 0.000 claims description 6
- 229910052698 phosphorus Inorganic materials 0.000 claims description 6
- 239000012460 protein solution Substances 0.000 claims description 6
- 239000011669 selenium Substances 0.000 claims description 6
- 229910052711 selenium Inorganic materials 0.000 claims description 6
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 claims description 6
- 239000011691 vitamin B1 Substances 0.000 claims description 6
- 239000011715 vitamin B12 Substances 0.000 claims description 6
- 239000011716 vitamin B2 Substances 0.000 claims description 6
- 239000011726 vitamin B6 Substances 0.000 claims description 6
- 235000019154 vitamin C Nutrition 0.000 claims description 6
- 239000011718 vitamin C Substances 0.000 claims description 6
- 235000019166 vitamin D Nutrition 0.000 claims description 6
- 239000011710 vitamin D Substances 0.000 claims description 6
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 6
- 229940046009 vitamin E Drugs 0.000 claims description 6
- 235000019165 vitamin E Nutrition 0.000 claims description 6
- 239000011709 vitamin E Substances 0.000 claims description 6
- 229940045997 vitamin a Drugs 0.000 claims description 6
- 229940046008 vitamin d Drugs 0.000 claims description 6
- 239000011701 zinc Substances 0.000 claims description 6
- 229910052725 zinc Inorganic materials 0.000 claims description 6
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 claims description 5
- 229930006000 Sucrose Natural products 0.000 claims description 5
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 5
- 108010046377 Whey Proteins Proteins 0.000 claims description 5
- 102000007544 Whey Proteins Human genes 0.000 claims description 5
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 claims description 5
- 239000001095 magnesium carbonate Substances 0.000 claims description 5
- 229910000021 magnesium carbonate Inorganic materials 0.000 claims description 5
- 229960001708 magnesium carbonate Drugs 0.000 claims description 5
- 235000014380 magnesium carbonate Nutrition 0.000 claims description 5
- 229960000869 magnesium oxide Drugs 0.000 claims description 5
- 239000005720 sucrose Substances 0.000 claims description 5
- 239000006188 syrup Substances 0.000 claims description 5
- 235000020357 syrup Nutrition 0.000 claims description 5
- 235000019155 vitamin A Nutrition 0.000 claims description 5
- 239000011719 vitamin A Substances 0.000 claims description 5
- 235000021119 whey protein Nutrition 0.000 claims description 5
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 4
- 239000000194 fatty acid Substances 0.000 claims description 4
- 229930195729 fatty acid Natural products 0.000 claims description 4
- -1 fatty acid ester Chemical class 0.000 claims description 4
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 claims description 4
- 239000011772 phylloquinone Substances 0.000 claims description 4
- 229920002148 Gellan gum Polymers 0.000 claims description 3
- 239000005913 Maltodextrin Substances 0.000 claims description 3
- 229920002774 Maltodextrin Polymers 0.000 claims description 3
- 235000019484 Rapeseed oil Nutrition 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims description 3
- 235000010418 carrageenan Nutrition 0.000 claims description 3
- 239000000679 carrageenan Substances 0.000 claims description 3
- 229920001525 carrageenan Polymers 0.000 claims description 3
- 229940113118 carrageenan Drugs 0.000 claims description 3
- 239000003240 coconut oil Substances 0.000 claims description 3
- 235000019864 coconut oil Nutrition 0.000 claims description 3
- 235000010492 gellan gum Nutrition 0.000 claims description 3
- 239000000216 gellan gum Substances 0.000 claims description 3
- 230000000887 hydrating effect Effects 0.000 claims description 3
- 229940035034 maltodextrin Drugs 0.000 claims description 3
- 239000002366 mineral element Substances 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 230000008569 process Effects 0.000 claims description 3
- 238000010008 shearing Methods 0.000 claims description 3
- 239000001384 succinic acid Substances 0.000 claims description 3
- 238000005303 weighing Methods 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims description 3
- DNISEZBAYYIQFB-PHDIDXHHSA-N (2r,3r)-2,3-diacetyloxybutanedioic acid Chemical compound CC(=O)O[C@@H](C(O)=O)[C@H](C(O)=O)OC(C)=O DNISEZBAYYIQFB-PHDIDXHHSA-N 0.000 claims description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 claims description 2
- 102000011632 Caseins Human genes 0.000 claims description 2
- 108010076119 Caseins Proteins 0.000 claims description 2
- 239000005715 Fructose Substances 0.000 claims description 2
- 229930091371 Fructose Natural products 0.000 claims description 2
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 claims description 2
- 229920000161 Locust bean gum Polymers 0.000 claims description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 claims description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 claims description 2
- 235000021323 fish oil Nutrition 0.000 claims description 2
- 239000001341 hydroxy propyl starch Substances 0.000 claims description 2
- 235000013828 hydroxypropyl starch Nutrition 0.000 claims description 2
- 235000010420 locust bean gum Nutrition 0.000 claims description 2
- 239000000711 locust bean gum Substances 0.000 claims description 2
- 239000002609 medium Substances 0.000 claims description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims description 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims description 2
- 238000004806 packaging method and process Methods 0.000 claims description 2
- 239000001814 pectin Substances 0.000 claims description 2
- 229920001277 pectin Polymers 0.000 claims description 2
- 235000010987 pectin Nutrition 0.000 claims description 2
- 229920000223 polyglycerol Polymers 0.000 claims description 2
- 239000003531 protein hydrolysate Substances 0.000 claims description 2
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 claims description 2
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 claims description 2
- 229940083466 soybean lecithin Drugs 0.000 claims description 2
- 239000003549 soybean oil Substances 0.000 claims description 2
- 235000012424 soybean oil Nutrition 0.000 claims description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims description 2
- 229940083542 sodium Drugs 0.000 claims 1
- 239000002245 particle Substances 0.000 abstract description 20
- 230000002776 aggregation Effects 0.000 abstract description 6
- 238000010438 heat treatment Methods 0.000 abstract description 6
- 238000003860 storage Methods 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 5
- 238000004220 aggregation Methods 0.000 abstract description 4
- 238000012545 processing Methods 0.000 abstract description 3
- 230000006920 protein precipitation Effects 0.000 abstract description 3
- 239000000047 product Substances 0.000 description 22
- 230000000694 effects Effects 0.000 description 13
- 229960005069 calcium Drugs 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 235000013305 food Nutrition 0.000 description 7
- 235000002639 sodium chloride Nutrition 0.000 description 7
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 6
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 6
- 230000001965 increasing effect Effects 0.000 description 6
- 239000011777 magnesium Substances 0.000 description 6
- 229910052749 magnesium Inorganic materials 0.000 description 6
- 229940091250 magnesium supplement Drugs 0.000 description 6
- 238000005259 measurement Methods 0.000 description 6
- 229960003975 potassium Drugs 0.000 description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 5
- 238000001556 precipitation Methods 0.000 description 5
- 229940091258 selenium supplement Drugs 0.000 description 5
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 4
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 4
- RMRCNWBMXRMIRW-BYFNXCQMSA-M cyanocobalamin Chemical compound N#C[Co+]N([C@]1([H])[C@H](CC(N)=O)[C@]\2(CCC(=O)NC[C@H](C)OP(O)(=O)OC3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)C)C/2=C(C)\C([C@H](C/2(C)C)CCC(N)=O)=N\C\2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O RMRCNWBMXRMIRW-BYFNXCQMSA-M 0.000 description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 4
- 229960002477 riboflavin Drugs 0.000 description 4
- 150000003839 salts Chemical class 0.000 description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 4
- 229940088594 vitamin Drugs 0.000 description 4
- 229930003231 vitamin Natural products 0.000 description 4
- 235000013343 vitamin Nutrition 0.000 description 4
- 239000011782 vitamin Substances 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 3
- 229930003451 Vitamin B1 Natural products 0.000 description 3
- 229930003779 Vitamin B12 Natural products 0.000 description 3
- 229930003471 Vitamin B2 Natural products 0.000 description 3
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000019799 monosodium phosphate Nutrition 0.000 description 3
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 3
- 235000005152 nicotinamide Nutrition 0.000 description 3
- 230000035764 nutrition Effects 0.000 description 3
- 238000005457 optimization Methods 0.000 description 3
- SHUZOJHMOBOZST-UHFFFAOYSA-N phylloquinone Natural products CC(C)CCCCC(C)CCC(C)CCCC(=CCC1=C(C)C(=O)c2ccccc2C1=O)C SHUZOJHMOBOZST-UHFFFAOYSA-N 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 3
- 238000004062 sedimentation Methods 0.000 description 3
- 239000011780 sodium chloride Substances 0.000 description 3
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 229960003495 thiamine Drugs 0.000 description 3
- 238000012795 verification Methods 0.000 description 3
- 235000010374 vitamin B1 Nutrition 0.000 description 3
- 235000019163 vitamin B12 Nutrition 0.000 description 3
- 235000019164 vitamin B2 Nutrition 0.000 description 3
- 235000019158 vitamin B6 Nutrition 0.000 description 3
- 229940011671 vitamin b6 Drugs 0.000 description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 3
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 2
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 description 2
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 2
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 2
- ABSPRNADVQNDOU-UHFFFAOYSA-N Menaquinone 1 Natural products C1=CC=C2C(=O)C(CC=C(C)C)=C(C)C(=O)C2=C1 ABSPRNADVQNDOU-UHFFFAOYSA-N 0.000 description 2
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 2
- VYGQUTWHTHXGQB-FFHKNEKCSA-N Retinol Palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-FFHKNEKCSA-N 0.000 description 2
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 2
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 238000005054 agglomeration Methods 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 235000010216 calcium carbonate Nutrition 0.000 description 2
- 239000001110 calcium chloride Substances 0.000 description 2
- 229910001628 calcium chloride Inorganic materials 0.000 description 2
- 229960002713 calcium chloride Drugs 0.000 description 2
- 235000011148 calcium chloride Nutrition 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- 229910000389 calcium phosphate Inorganic materials 0.000 description 2
- 229960001714 calcium phosphate Drugs 0.000 description 2
- 235000011010 calcium phosphates Nutrition 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 229910000365 copper sulfate Inorganic materials 0.000 description 2
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 2
- 229960002104 cyanocobalamin Drugs 0.000 description 2
- 235000000639 cyanocobalamin Nutrition 0.000 description 2
- 239000011666 cyanocobalamin Substances 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 2
- 230000002255 enzymatic effect Effects 0.000 description 2
- 229960002061 ergocalciferol Drugs 0.000 description 2
- 235000003891 ferrous sulphate Nutrition 0.000 description 2
- 239000011790 ferrous sulphate Substances 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 150000002500 ions Chemical class 0.000 description 2
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 2
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 2
- 239000011572 manganese Substances 0.000 description 2
- 229910052748 manganese Inorganic materials 0.000 description 2
- 235000002867 manganese chloride Nutrition 0.000 description 2
- 239000011565 manganese chloride Substances 0.000 description 2
- 229940099607 manganese chloride Drugs 0.000 description 2
- 229940099596 manganese sulfate Drugs 0.000 description 2
- 235000007079 manganese sulphate Nutrition 0.000 description 2
- 239000011702 manganese sulphate Substances 0.000 description 2
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 229960003966 nicotinamide Drugs 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 235000021049 nutrient content Nutrition 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- 235000019175 phylloquinone Nutrition 0.000 description 2
- MBWXNTAXLNYFJB-NKFFZRIASA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCC[C@H](C)CCC[C@H](C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-NKFFZRIASA-N 0.000 description 2
- 229960001898 phytomenadione Drugs 0.000 description 2
- 235000011164 potassium chloride Nutrition 0.000 description 2
- 239000001103 potassium chloride Substances 0.000 description 2
- 229960002816 potassium chloride Drugs 0.000 description 2
- 235000013926 potassium gluconate Nutrition 0.000 description 2
- 239000004224 potassium gluconate Substances 0.000 description 2
- 229960003189 potassium gluconate Drugs 0.000 description 2
- 235000018716 sodium selenate Nutrition 0.000 description 2
- 239000011655 sodium selenate Substances 0.000 description 2
- 229960001881 sodium selenate Drugs 0.000 description 2
- 229960000984 tocofersolan Drugs 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000001892 vitamin D2 Nutrition 0.000 description 2
- 239000011653 vitamin D2 Substances 0.000 description 2
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229960001763 zinc sulfate Drugs 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- OAVRWNUUOUXDFH-UHFFFAOYSA-H 2-hydroxypropane-1,2,3-tricarboxylate;manganese(2+) Chemical compound [Mn+2].[Mn+2].[Mn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O OAVRWNUUOUXDFH-UHFFFAOYSA-H 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- DPUOLQHDNGRHBS-UHFFFAOYSA-N Brassidinsaeure Natural products CCCCCCCCC=CCCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-UHFFFAOYSA-N 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- OCUCCJIRFHNWBP-IYEMJOQQSA-L Copper gluconate Chemical compound [Cu+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OCUCCJIRFHNWBP-IYEMJOQQSA-L 0.000 description 1
- IELOKBJPULMYRW-NJQVLOCASA-N D-alpha-Tocopheryl Acid Succinate Chemical compound OC(=O)CCC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C IELOKBJPULMYRW-NJQVLOCASA-N 0.000 description 1
- 235000000638 D-biotin Nutrition 0.000 description 1
- 239000011665 D-biotin Substances 0.000 description 1
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 1
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 1
- URXZXNYJPAJJOQ-UHFFFAOYSA-N Erucic acid Natural products CCCCCCC=CCCCCCCCCCCCC(O)=O URXZXNYJPAJJOQ-UHFFFAOYSA-N 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 1
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 1
- 239000004260 Potassium ascorbate Substances 0.000 description 1
- VYGQUTWHTHXGQB-UHFFFAOYSA-N Retinol hexadecanoate Natural products CCCCCCCCCCCCCCCC(=O)OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C VYGQUTWHTHXGQB-UHFFFAOYSA-N 0.000 description 1
- 229930003448 Vitamin K Natural products 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 description 1
- 229940100609 all-trans-retinol Drugs 0.000 description 1
- 239000011717 all-trans-retinol Substances 0.000 description 1
- 235000019169 all-trans-retinol Nutrition 0.000 description 1
- 230000004075 alteration Effects 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 235000013734 beta-carotene Nutrition 0.000 description 1
- 239000011648 beta-carotene Substances 0.000 description 1
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 description 1
- 229960002747 betacarotene Drugs 0.000 description 1
- 239000007853 buffer solution Substances 0.000 description 1
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 description 1
- 229940047036 calcium ascorbate Drugs 0.000 description 1
- 239000011692 calcium ascorbate Substances 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 235000008504 concentrate Nutrition 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 229940108925 copper gluconate Drugs 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 239000002285 corn oil Substances 0.000 description 1
- 235000005687 corn oil Nutrition 0.000 description 1
- 229940099418 d- alpha-tocopherol succinate Drugs 0.000 description 1
- 239000008367 deionised water Substances 0.000 description 1
- 229910021641 deionized water Inorganic materials 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary effect Effects 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- DPUOLQHDNGRHBS-KTKRTIGZSA-N erucic acid Chemical compound CCCCCCCC\C=C/CCCCCCCCCCCC(O)=O DPUOLQHDNGRHBS-KTKRTIGZSA-N 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000016615 flocculation Effects 0.000 description 1
- 238000005189 flocculation Methods 0.000 description 1
- DQOCFCZRZOAIBN-WZHZPDAFSA-L hydroxycobalamin Chemical compound O.[Co+2].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O DQOCFCZRZOAIBN-WZHZPDAFSA-L 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 239000012263 liquid product Substances 0.000 description 1
- 229910001607 magnesium mineral Inorganic materials 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 235000006748 manganese carbonate Nutrition 0.000 description 1
- 239000011656 manganese carbonate Substances 0.000 description 1
- 229940093474 manganese carbonate Drugs 0.000 description 1
- 235000014872 manganese citrate Nutrition 0.000 description 1
- 239000011564 manganese citrate Substances 0.000 description 1
- 229940097206 manganese citrate Drugs 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- 229910000016 manganese(II) carbonate Inorganic materials 0.000 description 1
- XMWCXZJXESXBBY-UHFFFAOYSA-L manganese(ii) carbonate Chemical compound [Mn+2].[O-]C([O-])=O XMWCXZJXESXBBY-UHFFFAOYSA-L 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000000693 micelle Substances 0.000 description 1
- 238000001471 micro-filtration Methods 0.000 description 1
- 239000011859 microparticle Substances 0.000 description 1
- 238000013508 migration Methods 0.000 description 1
- 230000005012 migration Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229940017794 potassium ascorbate Drugs 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- XOFYZVNMUHMLCC-ZPOLXVRWSA-N prednisone Chemical compound O=C1C=C[C@]2(C)[C@H]3C(=O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 XOFYZVNMUHMLCC-ZPOLXVRWSA-N 0.000 description 1
- 238000004393 prognosis Methods 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- WHOMFKWHIQZTHY-UHFFFAOYSA-L pyridoxine 5'-phosphate(2-) Chemical compound CC1=NC=C(COP([O-])([O-])=O)C(CO)=C1O WHOMFKWHIQZTHY-UHFFFAOYSA-L 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 229940108325 retinyl palmitate Drugs 0.000 description 1
- 235000019172 retinyl palmitate Nutrition 0.000 description 1
- 239000011769 retinyl palmitate Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- GQTHJBOWLPZUOI-FJXQXJEOSA-M sodium D-pantothenate Chemical compound [Na+].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O GQTHJBOWLPZUOI-FJXQXJEOSA-M 0.000 description 1
- 235000019188 sodium D-pantothenate Nutrition 0.000 description 1
- 239000011756 sodium D-pantothenate Substances 0.000 description 1
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 description 1
- 229960005055 sodium ascorbate Drugs 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000011083 sodium citrates Nutrition 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 235000019190 thiamine hydrochloride Nutrition 0.000 description 1
- 239000011747 thiamine hydrochloride Substances 0.000 description 1
- 229960000344 thiamine hydrochloride Drugs 0.000 description 1
- UIERGBJEBXXIGO-UHFFFAOYSA-N thiamine mononitrate Chemical compound [O-][N+]([O-])=O.CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N UIERGBJEBXXIGO-UHFFFAOYSA-N 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 235000019168 vitamin K Nutrition 0.000 description 1
- 239000011712 vitamin K Substances 0.000 description 1
- 150000003721 vitamin K derivatives Chemical class 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 229940046010 vitamin k Drugs 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- 239000002076 α-tocopherol Substances 0.000 description 1
- 235000004835 α-tocopherol Nutrition 0.000 description 1
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/10—Foods or foodstuffs containing additives; Preparation or treatment thereof containing emulsifiers
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
- A23L33/155—Vitamins A or D
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
- A23L33/165—Complexes or chelates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Nutrition Science (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Pediatric Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明涉及特殊医学用途全营养乳液技术领域,具体涉及一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物、特殊医学用途全营养乳液及其制备方法。为了解决特殊医学用途全营养乳液蛋白沉淀、脂肪上浮、加工或储藏期间褐变加剧的质量问题,通过将镁离子质量比为(2‑4):(2‑4):(2‑6)的硫酸镁、氧化镁和磷酸氢镁的混合物加入特殊医学用途全营养乳液中,通过不同镁盐类物质的选择及含量优化,在保证热处理强度的前提下,提高蛋白质的热稳定性,降低特殊医学用途全营养乳液中的粒径,减少乳液中粒子聚集的风险,减少褐变程度的发生,提高特殊医学用途全营养乳液的稳定性。
Description
技术领域
本发明涉及液体全营养乳液,具体涉及一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物、特殊医学用途全营养乳液及其制备方法。
背景技术
特殊医学用途配方食品(Food for Special Medical Purposes,FSMP)全营养乳液配合药物或手术治疗,对于疾病的转归、患者营养状况的改善具有积极的促进作用。据统计,2018年我国需要营养治疗的患者占住院人数的60%~70%,人数大致1.6亿人。如果仅按住院期间采用全营养治疗一次,特医食品的市场可达138亿元。并且随着我国社会老龄化的“加速”,40岁以上人群中慢性疾病患者人数呈现逐年快速增加的趋势,我国临床营养领域正面临着巨大的市场需求。
在临床应用上,与粉剂类产品相比,液态产品可直接食用或管饲,无需冲调,使用更加方便。根据GB29922的要求,参考《中国居民膳食营养素参考摄入量(2013版)》,研制营养全面均衡的特殊医学用途全营养配方食品具有重要的社会意义。
食品中蛋白质在受热处理都会有不同程度的蛋白变性、颜色的变化。全营养乳液是一个成分复杂的缓冲体系,原料种类繁多且蛋白质、脂肪、矿物质、维生素含量高。全营养乳液体系在热力学上属于不稳定体系:既有蛋白质等微粒形成的悬浮液、脂肪乳浊液,又有以糖、盐类形成的真溶液。现有的全营养乳液体系存在的主要质量问题为加工及贮藏中出现蛋白沉淀、脂肪上浮、矿物质参与加工过程中产生美拉德反应引发褐变加剧等。从微观上表现为乳状液分散相颗粒的迁移(表现为沉淀和析水),或是分散相颗粒粒径大小的变化(表现为团聚和絮凝)。
FSMP对全营养乳液中的矿物质和维生素的含量有更高和更全面的要求。全营养乳液体系中铜、铁、钠、钾等矿物质对FSMP产品的贮藏特性也有较大的影响。不同形式的矿物质对于溶液体系的酸碱平衡影响不同。液体体系的pH值会影响到蛋白质的稳定以及热处理过程中褐变的程度。
总体来说凡是影响全营养乳液中蛋白质稳定性的因素,破坏蛋白结构稳定性的因素都会影响产品的稳定性,例如稳定剂、乳液体系的pH、矿物质盐等因素都会影响到产品的稳定性。不适当的稳定体系会导致体系中蛋白粒径增大,易发生聚集、团聚;酪蛋白胶体钙与离子钙之间的盐类平衡被打破等等都会造成产品稳定性下降。为提高全营养乳液的稳定性,现有技术多从增稠剂、乳化剂配方优化、热处理参数优化、耐热性蛋白质原料的选择来考虑,但收效甚微。
发明内容
不同形式的矿物质对于溶液体系的酸碱平衡影响不同。液体体系的pH值会影响到蛋白质的稳定以及热处理过程中褐变的程度。为了解决全营养乳液蛋白沉淀、脂肪上浮、加工或储藏期间褐变加剧的质量问题,本发明提供一种用于提高液体全营养乳液稳定性的镁盐组合物以及一种特殊医学用途全营养乳液及其制备方法。本发明通过不同盐类的物质的选择及含量优化,在保证热处理强度的前提下,提高蛋白质的热稳定性,降低全营养乳液中物质的粒径,减少乳液中粒子聚集的风险,减少褐变程度的发生,提高全营养乳液的稳定性。
本发明的技术方案之一,一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物,所述镁盐组合物为硫酸镁、碳酸镁、氧化镁、葡萄糖酸镁以及磷酸氢镁中的任意两种或多种混合物。
进一步地,所述镁盐组合物为镁离子质量比为(2-4):(2-4):(2-6)的硫酸镁、氧化镁和磷酸氢镁的混合物。
本发明的技术方案之二,一种提高特殊医学用途全营养乳液稳定性的方法,将上述的镁盐组合物添加入液体全营养乳液中,使特殊医学用途全营养乳液中镁离子的含量为183-285mg/L。
本发明将镁盐组合物添加入特殊医学用途全营养乳液中,一方面镁盐组合物提供全营养乳液中镁的来源,另一方面这种镁盐组合物可以提高全营养乳液稳定性,减轻产品褐变的发生。镁离子浓度过低不能满足全营养乳液标准要求,镁离子浓度太高,易造成蛋白质变性,耐热性下降,褐变严重,从而影响乳液稳定性。
本发明的技术方案之三,一种特殊医学用途全营养乳液,按质量份数计,原料包括:蛋白类原料35.6~87.5份、脂肪20~45.5份、碳水化合物105.7~241.93份、膳食纤维0~30份、稳定剂1~5份、乳化剂1~5份、矿物质预混料1~10份、镁盐组合物0.2~1.5份、维生素预混料0.2~1份;其中所述镁盐组合物为硫酸镁、碳酸镁、氧化镁、葡萄糖酸镁以及磷酸氢镁中的两种或多种混合物。
进一步地,所述镁盐组合物为镁离子质量比为(2-4):(2-4):(2-6)的硫酸镁、氧化镁和磷酸氢镁的混合物。
进一步地,所述蛋白类原料选自酪蛋白、乳清蛋白和乳清蛋白水解物中的一种或多种混合物;
所述脂肪选自菜籽油、椰子油、鱼油、大豆油和中链甘油三酸酯中的一种或多种混合物;
所述碳水化合物选自葡萄糖浆、葡萄糖浆干粉、麦芽糊精、蔗糖、葡萄糖和果糖中的一种或几种;
所述稳定剂选自卡拉胶、微晶纤维素、羧甲基纤维素钠、黄原胶、结冷胶、果胶、羟丙基淀粉和刺槐豆胶中的一种或几种;
乳化剂选自聚甘油脂肪酸酯、蔗糖脂肪酸酯、双乙酰酒石酸单双甘油酯、大豆磷脂、单双甘油脂肪酸酯和琥珀酸单甘油酯中的一种或几种;
矿物质预混料包括以下矿物质元素:铜、铁、锌、钠、钾、锰、钙、磷、氯和硒;其中铜来源于硫酸铜、葡萄糖酸铜、柠檬酸铜、碳酸铜中的一种或两种;铁来源于硫酸亚铁、葡萄糖酸亚铁、焦磷酸铁、柠檬酸铁铵、富马酸亚铁、柠檬酸铁中的一种或几种;锌来源于硫酸锌、葡萄糖酸锌、氧化锌、乳酸锌、柠檬酸锌、氯化锌、乙酸锌中的一种或两种;钠来源于碳酸氢钠、磷酸二氢钠、柠檬酸钠、氯化钠、磷酸氢二钠中的一种或几种;钾来源于葡萄糖酸钾、氯化钾、柠檬酸钾、磷酸二氢钾、磷酸氢二钾中的一种或几种;锰来源于硫酸锰、氯化锰、碳酸锰、柠檬酸锰、葡萄糖酸锰中的一种或两种;钙来源于碳酸钙、葡萄糖酸钙、柠檬酸钙、L-乳酸钙、氯化钙、磷酸钙、磷酸氢钙、氧化钙、硫酸钙中的一种或几种;所述磷来源于磷酸二氢钠、磷酸氢二钠、磷酸二氢钾、磷酸氢二钾、磷酸钙、磷酸氢钙中的一种或几种;所述氯来源于氯化钠、氯化钾、氯化锰、氯化钙中的一种或几种;硒来源于硒酸钠、亚硒酸钠中的一种或几种。
维生素预混料中含有以下任一种或几种组分:维生素A、维生素D、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、烟酰胺、叶酸、泛酸、维生素C、生物素和碘。本发明所述维生素A来源于维生素A棕榈酸酯、维生素A醋酸酯、β-胡萝卜素、全反式视黄醇中的一种或几种;维生素D来源于胆钙化醇(维生素D3)、麦角钙化醇(维生素D2);维生素E来源于d-α-生育酚、dl-α-生育酚、d-α-醋酸生育酚、dl-α-醋酸生育酚、混合生育酚浓缩物、d-α-琥珀酸生育酚、dl-α-琥珀酸生育酚中的一种或两种;维生素B1来源于盐酸硫胺素、硝酸硫胺素中的一种或两种;维生素B2来源于核黄素、核黄素-5′-磷酸钠中的一种或两种;维生素B6来源于盐酸吡哆醇、5′-磷酸吡哆醇中的一种或两种;维生素B12来源于氰钴胺、烟酸氰钴胺、羟钴胺中的一种或两种;烟酰胺来源于烟酸、烟酰胺中的一种或两种;叶酸来源于叶酸;泛酸来源于D-泛酸钙、D-泛酸钠中的一种或两种;维生素C来源于抗坏血酸、L-抗坏血酸钠、L-抗坏血酸钙、L-抗坏血酸钾、抗坏血酸棕榈酸酯中的一种或两种;生物素来源于D-生物素;碘来源于碘化钾、碘酸钾、碘化钠中的一种或两种。
其中维生素预混料中维生素A、维生素D、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、烟酰胺、叶酸、泛酸、维生素C、生物素和碘的混合质量比以及矿物质预混料中矿物质离子的质量比遵循表1限定范围。本发明所用各原料用量符合法规例如GB29922要求。制得的特殊医学用途全营养乳液的营养成分应符合表1所示。
表1全营养乳液营养素含量
本发明的技术方案之四,上述特殊医学用途全营养乳液的制备方法,包括以下步骤:
(1)取蛋白类原料溶解于水中搅拌混合均匀后静置水合得到蛋白溶液A;将稳定剂和乳化剂溶解于水中搅拌混合均匀后加入脂肪剪切形成油相溶液B;将蛋白溶液A和油相溶液B混合形成混合溶液C;
(2)取碳水化合物类原料、膳食纤维溶解于热水中搅拌混合均匀得到溶液D。将混合溶液C与溶液D混合形成溶液E;
(3)称取矿物质预混料和镁盐组合物,加入热水中搅拌溶解得溶液F;维生素预混料溶解于热水中搅拌溶解得溶液G;
(4)溶液F和溶液G分别加入混合溶液E中搅拌混合、定容。然后预热,均质,灭菌包装得所述特殊医学用途全营养乳液。
进一步地,所述步骤(1)中蛋白类原料溶解于40-50℃热水中,稳定剂和乳化剂溶解于40-80℃热水中;
进一步地,所述步骤(2)和步骤(3)中热水温度40-60℃;
进一步地,所述步骤(4)中预热温度55-65℃,均质压力20-40MPa;灭菌设备为杀菌釜(条件为121-125℃,20-30min)或超高温瞬时灭菌机(条件为130-140℃,15-30秒)。
与现有技术相比,本发明具有以下有益效果:
本发明中的特殊医学用途全营养乳液能量密度为1-1.5kcal/mL。特殊医学用途全营养乳液的原料包括蛋白质、脂肪、乳化剂、碳水化合物、膳食纤维、维生素、矿物质和稳定剂,所用的原料及产品中营养素含量要求需符合《GB29922食品安全国家标准特殊医学用途配方食品通则》中对于特殊医学用途全营养配方食品的要求。
通过向特殊医学用途全营养乳液中加入镁盐组合物,使得全营养乳液成品的粒径有了大幅降低,离心沉淀率降低至1.56%。在本发明提供的镁盐组合物既可以添加入预混料中作为镁矿物质引入,也可以作为原料单独添加,优选的方案中,镁盐组合物作为原料单独添加,这样更有助于对产品pH值以及粒径的调整,使产品的性能更佳。
附图说明
图1为本发明实施例2制备的含镁盐组合物的特殊医学用途全营养乳液32℃储藏条件下色差变化图。
具体实施方式
现详细说明本发明的多种示例性实施方式,该详细说明不应认为是对本发明的限制,而应理解为是对本发明的某些方面、特性和实施方案的更详细的描述。
应理解本发明中所述的术语仅仅是为描述特别的实施方式,并非用于限制本发明。另外,对于本发明中的数值范围,应理解为还具体公开了该范围的上限和下限之间的每个中间值。在任何陈述值或陈述范围内的中间值以及任何其他陈述值或在所述范围内的中间值之间的每个较小的范围也包括在本发明内。这些较小范围的上限和下限可独立地包括或排除在范围内。
除非另有说明,否则本文使用的所有技术和科学术语具有本发明所述领域的常规技术人员通常理解的相同含义。虽然本发明仅描述了优选的方法和材料,但是在本发明的实施或测试中也可以使用与本文所述相似或等同的任何方法和材料。本说明书中提到的所有文献通过引用并入,用以公开和描述与所述文献相关的方法和/或材料。在与任何并入的文献冲突时,以本说明书的内容为准。
在不背离本发明的范围或精神的情况下,可对本发明说明书的具体实施方式做多种改进和变化,这对本领域技术人员而言是显而易见的。由本发明的说明书得到的其他实施方式对技术人员而言是显而易见得的。本申请说明书和实施例仅是示例性的。
关于本文中所使用的“包含”、“包括”、“具有”、“含有”等等,均为开放性的用语,即意指包含但不限于。
本发明以下实施例中,碳水化合物质量比为3:1:1的麦芽糊精、蔗糖、葡萄糖浆混合物;使用的稳定剂为质量比为5:1:4的黄原胶、卡拉胶、结冷胶;乳化剂为琥珀酸单甘油酯;矿物质预混料包括以下矿物质元素:铜、铁、锌、钠、钾、锰、钙、磷、氯、硒(金属元素质量比:铜:铁:锌:钠:钾:锰:钙:磷:氯:硒=660:13:10:890:1300:2800:580:540:1660:0.042);其中铜来源于硫酸铜、铁来源于硫酸亚铁、锌来源于硫酸锌、钠来源于碳酸氢钠、钾来源于葡萄糖酸钾、锰来源于硫酸锰、钙来源于碳酸钙、磷来源于磷酸二氢钠、氯来源于氯化钠、硒来源于硒酸钠。维生素预混料中含有维生素A、维生素D、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、烟酰胺、叶酸、泛酸、维生素C、生物素和碘(维生素A、维生素D、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、烟酰胺、叶酸、泛酸、维生素C、生物素和碘质量比=840:15:15400:66:1700:1600:1700:3.5:1600:430:3900:145000:33:95)。镁来源于硫酸镁、葡萄糖酸镁、氧化镁、碳酸镁、磷酸氢镁或镁盐组合物。产品中镁离子的含量为183-285mg/L。
实施例1
分别采用硫酸镁、葡萄糖酸镁、氧化镁、碳酸镁、磷酸氢镁、镁盐组合物(硫酸镁∶氧化镁∶磷酸氢镁质量比为3∶3∶4)作为镁盐,制备含有不同镁盐的特殊医学用途全营养乳液,镁盐的添加量以使产品中镁离子的含量为234mg/L为度(其中,镁盐组合物添加量为1.215份);具体制备方法如下:
(1)称取原料:蛋白类原料(具体为质量比为2:1的酪蛋白和乳清蛋白)47份、低芥酸菜籽油8份、玉米油9份、椰子油3.2份、碳水化合物200份、膳食纤维27份、稳定剂3份、乳化剂3份、矿物质预混料7.8份、、维生素预混料0.332份;
(2)取蛋白类原料溶解于50℃热水中搅拌混合均匀后静置水合得到蛋白溶液A;将稳定剂和乳化剂溶解于50℃热水中搅拌混合均匀后加入脂肪剪切形成油相溶液B;将蛋白溶液A和油相溶液B混合形成混合溶液C;取碳水化合物类原料、膳食纤维溶解于50℃热水中搅拌混合均匀得到溶液D。将混合溶液C与溶液D混合形成溶液E。
(3)取矿物质和镁盐,加入60℃热水中搅拌溶解得溶液F;维生素溶解于60℃热水中搅拌溶解得溶液G;
(4)溶液F和溶液G分别加入混合溶液E中搅拌混合后,定容至1L。60℃预热,30MPa压力下均质,转入杀菌釜二次灭菌,灭菌条件为121-125℃,25min。灭菌结束后冷却至40℃。得所述特殊医学用途全营养乳液。
对制备的特殊医学用途全营养乳液进行性能验证,具体验证过程如下:
①离心沉淀率(WHC)的测定:用吸管吸取25mL待测样品于离心管中。测定样品质量m0后,放入离心机,以10000r/min离心10min后,取出离心管,除去上清液,静止倒置10min后,测离心管中残余物的质量m,每个样品进行3次平行测定,取平均值。计算离心沉淀率。
②平均粒径的测定:室温下将待测样品与去离子水按照1:1000稀释后,过0.45μm微滤膜过滤,利用纳米平均粒径电位分析仪,将Zeta电位仪设置为平均粒径进行检测。
③pH测定:将样品置于25℃至恒温。利用pH计测定样品的pH,每个样品平行测定3次,取算术平均值。
④粘度测定:将常温样品缓慢倒入200mL容器内,将转子置于乳液内,液体没过转子刻度。测定参数:61号转子,50rpm,30s。共测定三次,取其平均值。
⑤色差测定:打开色差计,进行白板校正。向样品池中加入适量振荡均匀的样品并盖好盖,测定样品的L、a和b值,用以评价褐变度。其中L*代表亮度,能够指示由于酶促褐变或是非酶促褐变引起的色素聚集导致的变暗程度,即L值越大,产品色泽偏亮,产品褐变程度越轻。a代表的范围是从红色(+)到绿色(-),即a值越大,产品色泽偏红;b代表的范围是从黄色到蓝色,即b值越大,产品色泽偏黄。共测定三次,取其平均值。
⑥物理稳定性:采用LUMiSizer快速稳定性分析仪进行测定,以Slope值进行表征,Slope值越小代表产品物理稳定性越好。本实验采用稳定性分析测定slop值评价分析产品物理稳定性,产品稳定性好,说明保质期会更好。
检测结果见表2;
表2不同镁盐及镁盐组合物对全营养乳液稳定性的影响
注:色差采用Turkey分析,大写字母表示0.01水平显著。
不同形式的矿物质对于溶液体系的酸碱平衡影响不同。液体体系的pH值会影响到蛋白质的稳定以及热处理过程中褐变的程度。不同的镁盐对全营养乳液体系的影响不同。不同形式的镁盐添加可导致全营养乳液的pH值产生一定的波动(6.50-7.00)。一般来说,美拉德反应易在高pH环境发生并加剧,酸性或弱酸性环境会降低或减缓美拉德反应。但对于含酪蛋白或酪蛋白含量高的液体体系,高pH或偏弱碱性环境有益于酪蛋白胶束结构的维持,热稳定性增加。
由上表可知,氧化镁对全营养乳液成品的pH调节能力较强。氧化镁的添加可调节全营养乳液pH至偏中性,为7.02。此时全营养乳液沉淀率较低(1.23%),粒径在434nm左右,蛋白稳定性较好。添加硫酸镁与葡萄糖酸镁的全营养乳液pH为6.59、6.67。全营养乳液粒径较高,为600-700nm,体系不稳定性因素增加;磷酸氢镁对全营养乳液成品的pH调节能力不强,其乳液的pH为6.52,粒径在346nm。相比于添加硫酸镁、葡萄糖酸镁、氧化镁的全营养乳液,通过优化镁盐的组成,对体系的pH进行调整,添加镁盐优化组合物的全营养的乳液粒径为342nm,粒径有了大幅度的降低;沉淀率降低至1.56%。
由表2可以得出,不同镁盐对全营养乳液色差有影响。氧化镁对全营养乳液褐变影响较大,即对亮度(L值)、红绿色(a值)、黄蓝色(b值)有显著影响。其中氧化镁的添加导致全营养乳液色泽较暗,L值较低;a值较高,全营养乳液偏红。从色差值来看,硫酸镁、葡萄糖酸镁以及镁盐优化组合物对于全营养乳液褐变的影响较少,即分别添加硫酸镁、葡萄糖酸镁、镁盐优化组合物的L值较大,全营养乳液亮度较高;a值显著低于氧化镁的a值,产品褐变不严重。葡萄糖酸镁和硫酸镁对全营养乳液的影响基本一致,相比于葡萄糖酸镁,硫酸镁对其他指标比如粒径、沉淀率影响更小。
综合考虑镁对全营养乳液中蛋白质的稳定性(pH、粒径、沉淀率)以及产品褐变(色差)的影响:镁盐优化组合物的最优组合为硫酸镁、氧化镁以及磷酸氢镁。其对全营养乳液的褐变的影响较少,且全营养乳液的稳定性提高较多。
将制得的添加镁盐组合物的特殊医学用途全营养乳液进行营养成分分析,
结果见表3;
表3全营养乳液营养素含量
实施例2
其他同实施例1,区别在于,分别采用硫酸镁盐和镁盐组合物(质量比:硫酸镁:氧化镁:磷酸氢镁=2:4:4)制备不同镁盐的特殊医学用途全营养乳液,使特殊医学用途全营养乳液中最终镁离子含量为234mg/L;
具体制备方法同实施例1,区别在于,杀菌采用超高温瞬时灭菌,灭菌条件137℃,30秒。对产品进行性能验证,结果见表4;
表4硫酸镁与镁盐组合物对全营养乳液稳定性的影响
注:**表示与对照相比,P<0.01
表3可以得出,采用本发明的镁盐优化组合物作为全营养乳液中镁的来源,全营养乳液中的粒径有了显著的降低,为350nm,溶液的pH升高至7.01,其Slope值也显著低于对照,进一步表明镁盐优化组合物对特殊医学用途全营养乳液的物理稳定性具有提高改善作用。
色差值△E,0~0.5为极小差异,0.5~1.5为稍有差异,1.5~3.0为有差异,3.0~6.0为差异显著,6.0~12.0为差异极显著,12.0以上为不同颜色。本实验对比了普通镁盐和本发明中的镁盐优化组合物在全营养乳液中的影响。研究结果显示:与添加硫酸镁的全营养乳液相比,添加镁盐优化组合物的全营养乳液的亮度偏亮(L值高于对照组的L值),红色的色泽减轻(a值小于对照组的a值)。相比于对照组,使用镁盐优化组合物的全营养乳液褐变极大地减轻。本实验中△E为3.83(大于3.0),表明使用镁盐优化组合物后,全营养乳液的褐变极大地改善。
将制得的添加镁盐优化组合物的全营养乳液放置在32℃条件下储存,考察褐变情况,结果见图1;结果显示,随着全营养乳液样品在32℃储藏时间的增加,其总色差值在整体上成上升趋势,但小于2.0,未达显著。表明样品在32℃储存后颜色没有明显改变,产品的稳定性较好。
同时在本发明的进一步实验验证方案中发现,当将实施例以及实施例1所述的镁盐组合物先添加入矿物质预混料中,然后再用于制备全营养乳液时,也能起到提高全营养乳液稳定性的效果。但是镁盐组合物作为原料单独添加时更有助于对产品pH值以及粒径的调整,使产品的性能更佳。
以上所述仅为本发明的较佳实施例,并不用以限制本发明,凡在本发明的精神和原则之内所作的任何修改、等同替换和改进等,均应包含在本发明的保护范围之内。
Claims (7)
1.一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物,其特征在于,所述镁盐组合物为硫酸镁、碳酸镁、氧化镁、葡萄糖酸镁以及磷酸氢镁中的任意两种或多种混合物。
2.根据权利要求1所述的一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物,其特征在于,所述镁盐组合物为镁离子质量比为(2-4):(2-4):(2-6)的硫酸镁、氧化镁和磷酸氢镁的混合物。
3.一种提高特殊医学用途全营养乳液稳定性的方法,其特征在于,将权利要求1-2任一项所述的镁盐组合物添加入特殊医学用途全营养乳液中,使特殊医学用途全营养乳液中镁离子的含量为183-285mg/L。
4.一种特殊医学用途全营养乳液,其特征在于,以质量份数计,原料包括:蛋白类原料35.6~87.5份、脂肪20~45.5份、碳水化合物105.7~241.93份、膳食纤维0~30份、稳定剂1~5份、乳化剂1~5份、矿物质预混料1~10份、镁盐组合物0.2~1.5份、维生素预混料0.2~1份;其中所述镁盐组合物为权利要求1-2任一项所述镁盐组合物。
5.根据权利要求4所述的特殊医学用途全营养乳液,其特征在于,
所述蛋白类原料选自酪蛋白、乳清蛋白和乳清蛋白水解物中的一种或多种混合物;
所述脂肪选自菜籽油、椰子油、鱼油、大豆油和中链甘油三酸酯中的一种或多种混合物;
所述碳水化合物选自葡萄糖浆、葡萄糖浆干粉、麦芽糊精、蔗糖、葡萄糖、果糖中的一种或几种;
所述稳定剂选自卡拉胶、微晶纤维素、羧甲基纤维素钠、黄原胶、结冷胶、果胶、羟丙基淀粉和刺槐豆胶中的一种或几种;
乳化剂选自聚甘油脂肪酸酯、蔗糖脂肪酸酯、双乙酰酒石酸单双甘油酯、大豆磷脂、单双甘油脂肪酸酯和琥珀酸单甘油酯中的一种或几种;
矿物质预混料包括以下矿物质元素:铜、铁、锌、钠、钾、锰、钙、磷、氯和硒;
维生素预混料含有以下任一种或几种组分:维生素A、维生素D、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、烟酰胺、叶酸、泛酸、维生素C、生物素和碘。
6.一种根据权利要求4-5任一项所述的特殊医学用途全营养乳液的制备方法,其特征在于,包括以下步骤:
(1)取蛋白类原料溶解于水中搅拌混合均匀后静置水合得到蛋白溶液A;将稳定剂和乳化剂溶解于水中搅拌混合均匀后加入脂肪剪切形成油相溶液B;将蛋白溶液A和油相溶液B混合形成混合溶液C;
(2)取碳水化合物类原料、膳食纤维溶解于热水中搅拌混合均匀得到溶液D;将混合溶液C与溶液D混合形成溶液E;
(3)称取矿物质预混料和镁盐组合物,加入热水中搅拌溶解得溶液F;维生素预混料溶解于热水中搅拌溶解得溶液G;
(4)溶液F和溶液G分别加入混合溶液E中搅拌混合后、定容、预热,均质,灭菌包装得所述特殊医学用途全营养乳液。
7.根据权利要求6所述的特殊医学用途全营养乳液的制备方法,其特征在于,
所述步骤(1)中蛋白类原料溶解于40-50℃热水中,稳定剂和乳化剂溶解于40-80℃热水中;
所述步骤(2)和步骤(3)中热水温度40-60℃;
所述步骤(4)中预热温度55-65℃,均质压力20-40mpa;灭菌条件为杀菌釜二次灭菌,灭菌温度为121-125℃,灭菌时间20-30min;或者超高温瞬时灭菌,灭菌温度为130-140℃,灭菌时间15-30秒。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110242945.4A CN112971147B (zh) | 2021-03-05 | 2021-03-05 | 一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202110242945.4A CN112971147B (zh) | 2021-03-05 | 2021-03-05 | 一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN112971147A true CN112971147A (zh) | 2021-06-18 |
CN112971147B CN112971147B (zh) | 2022-08-05 |
Family
ID=76352877
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202110242945.4A Active CN112971147B (zh) | 2021-03-05 | 2021-03-05 | 一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN112971147B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115644429A (zh) * | 2022-11-21 | 2023-01-31 | 华南理工大学 | 一种乳清蛋白-豆类蛋白共稳定的全营养特殊医学用途配方食品乳剂及其制备方法 |
CN115997924A (zh) * | 2023-02-13 | 2023-04-25 | 希欧七(北京)营养科技有限公司 | 一种稳定的蛋白纳米营养乳液及其制备方法 |
CN116369513A (zh) * | 2023-03-15 | 2023-07-04 | 江南大学 | 一种不添加额外稳定剂的特殊医学用途全营养乳液及其制备方法 |
Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4497800A (en) * | 1982-07-06 | 1985-02-05 | Mead Johnson & Company | Stable liquid diet composition |
CN107440098A (zh) * | 2017-08-11 | 2017-12-08 | 浙江益元素食品有限公司 | 一种全营养特殊医学用途乳剂及其制备方法 |
CN109045278A (zh) * | 2018-07-09 | 2018-12-21 | 苏州恒瑞健康科技有限公司 | 一种稳定的乳蛋白质液态体系及其应用 |
CN110214940A (zh) * | 2019-07-05 | 2019-09-10 | 山东特康药业有限公司 | 一种成年人全营养特殊医学用途配方营养液及其制备方法 |
CN110604213A (zh) * | 2019-09-09 | 2019-12-24 | 苏州恒瑞健康科技有限公司 | 一种提高蛋白质稳定性的工艺方法 |
CN111194912A (zh) * | 2019-07-09 | 2020-05-26 | 北京市营养源研究所 | 一种稳定的医用液态肠内营养组合物及其制备方法 |
CN112385827A (zh) * | 2020-09-24 | 2021-02-23 | 特康药业集团有限公司 | 高能量密度酪蛋白型全营养特医食品乳剂及其制备方法 |
-
2021
- 2021-03-05 CN CN202110242945.4A patent/CN112971147B/zh active Active
Patent Citations (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4497800A (en) * | 1982-07-06 | 1985-02-05 | Mead Johnson & Company | Stable liquid diet composition |
CN107440098A (zh) * | 2017-08-11 | 2017-12-08 | 浙江益元素食品有限公司 | 一种全营养特殊医学用途乳剂及其制备方法 |
CN109045278A (zh) * | 2018-07-09 | 2018-12-21 | 苏州恒瑞健康科技有限公司 | 一种稳定的乳蛋白质液态体系及其应用 |
CN110214940A (zh) * | 2019-07-05 | 2019-09-10 | 山东特康药业有限公司 | 一种成年人全营养特殊医学用途配方营养液及其制备方法 |
CN111194912A (zh) * | 2019-07-09 | 2020-05-26 | 北京市营养源研究所 | 一种稳定的医用液态肠内营养组合物及其制备方法 |
CN110604213A (zh) * | 2019-09-09 | 2019-12-24 | 苏州恒瑞健康科技有限公司 | 一种提高蛋白质稳定性的工艺方法 |
CN112385827A (zh) * | 2020-09-24 | 2021-02-23 | 特康药业集团有限公司 | 高能量密度酪蛋白型全营养特医食品乳剂及其制备方法 |
Non-Patent Citations (2)
Title |
---|
刘鹭等: "酪蛋白酸钠美拉德反应产物的制备及其乳化特性", 《食品科学》 * |
朱巧梅等: "乳化剂与内水相镁盐浓度对油包水乳液稳定性的影响", 《农业机械学报》 * |
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115644429A (zh) * | 2022-11-21 | 2023-01-31 | 华南理工大学 | 一种乳清蛋白-豆类蛋白共稳定的全营养特殊医学用途配方食品乳剂及其制备方法 |
CN115644429B (zh) * | 2022-11-21 | 2024-05-03 | 华南理工大学 | 一种乳清蛋白-豆类蛋白共稳定的全营养特殊医学用途配方食品乳剂 |
CN115997924A (zh) * | 2023-02-13 | 2023-04-25 | 希欧七(北京)营养科技有限公司 | 一种稳定的蛋白纳米营养乳液及其制备方法 |
CN115997924B (zh) * | 2023-02-13 | 2023-11-28 | 希欧七(北京)营养科技有限公司 | 一种稳定的蛋白纳米营养乳液及其制备方法 |
CN116369513A (zh) * | 2023-03-15 | 2023-07-04 | 江南大学 | 一种不添加额外稳定剂的特殊医学用途全营养乳液及其制备方法 |
CN116369513B (zh) * | 2023-03-15 | 2024-03-01 | 江南大学 | 一种不添加额外稳定剂的特殊医学用途全营养乳液及其制备方法 |
Also Published As
Publication number | Publication date |
---|---|
CN112971147B (zh) | 2022-08-05 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN112971147B (zh) | 一种用于提高特殊医学用途全营养乳液稳定性的镁盐组合物 | |
CN111194912B (zh) | 一种稳定的医用液态肠内营养组合物及其制备方法 | |
CN102429024B (zh) | 一种营养均衡长保质期的儿童液态奶及其制备方法 | |
Taylor et al. | Relationships among iron absorption, percent saturation of plasma transferrin and serum ferritin concentration in humans | |
CN105532919B (zh) | 一种全营养儿童配方乳粉及其制备方法 | |
US20220330571A1 (en) | Field bean protein composition | |
Pathomrungsiyounggul et al. | Effect of calcium carbonate, calcium citrate, tricalcium phosphate, calcium gluconate and calcium lactate on some physicochemical properties of soymilk | |
Rahman et al. | Double‐blind cluster randomised controlled trial of wheat flour chapatti fortified with micronutrients on the status of vitamin A and iron in school‐aged children in rural B angladesh | |
Giorgini et al. | The use of sweet rolls fortified with iron bis-glycinate chelate in the prevention of iron deficiency anemia in preschool childrel | |
Milne et al. | Folate status of adult males living in a metabolic unit: possible relationships with iron nutriture | |
Črnivec et al. | Thermal protection and pH-gated release of folic acid in microparticles and nanoparticles for food fortification | |
Halverson et al. | Relation of iodine to the goitrogenic properties of soybeans | |
CN115474690A (zh) | 一种以植物整蛋白为唯一蛋白来源的全营养特殊医学用途配方食品乳剂及其制备方法 | |
CN106615141B (zh) | 牛乳蛋白-阴离子多糖乳化稳定剂及其应用 | |
CN109674038A (zh) | 一种口服全营养组合物 | |
CN113925157A (zh) | 一种β-胡萝卜素乳液及其制备方法 | |
CN104770815A (zh) | 含悬浮甜玉米粒的玉米浓浆谷物饮料及其制作方法 | |
CN105136790B (zh) | 一种牛肉汞含量的检测方法 | |
CN114365841B (zh) | 一种适用于肾病患者的全营养乳及其制备方法 | |
WO2023180103A1 (en) | Kit of parts and microbiological method for assessment of the folate status in serum and red blood cells | |
CN115024455A (zh) | 一种低gi苦荞浓浆饮料的加工工艺及其体外消化性测定的方法 | |
CN113712197A (zh) | 一种呼吸系统疾病用营养组合物及其制备方法 | |
Śmigielska et al. | Research on zinc fortified potato starch and on its use in dessert production | |
CN114145452A (zh) | 特殊医学用途全营养配方食品 | |
CN116369513B (zh) | 一种不添加额外稳定剂的特殊医学用途全营养乳液及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information | ||
CB02 | Change of applicant information |
Address after: 100071 No.4, Dongbinhe Road, Fengtai District, Beijing Applicant after: Beijing Nutrition Research Institute Co.,Ltd. Address before: 100071 No.4, Dongbinhe Road, Fengtai District, Beijing Applicant before: BEIJING Research Institute FOR NUTRITIONAL RESOURCES |
|
GR01 | Patent grant | ||
GR01 | Patent grant |